|
|
Healthcare Global Enterprises Ltd (HCG) is Bangalore India based provider of speciality healthcare in India focused on cancer and fertility.
HCG operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. HCG also operates fertility centres under the 'Milann' brand.
As of December 31, 2015, HCG network consisted of 14 comprehensive cancer centres, including centre of excellence in Bengaluru, three freestanding diagnostic centres and one day care chemotherapy centre across India.
HCG acquired 50.10% equity in BACC Healthcare in 2013 which operates fertility centres under the Milann brand, through itself and its wholly-owned subsidiary, DKR Healthcare. HCG now operate four Milann fertility centres in Bengaluru. BACC Healthcare is led by a team of qualified and experienced fertility specialists. Its founder, Dr. Kamini Rao has a successful track record of over 25 years of providing fertility treatments. Milann fertility centres provide comprehensive reproductive medicine services, including assisted reproduction, gynaecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment.
Under Triesta brand, HCG provide clinical reference laboratory services in India with a specialisation in oncology, including molecular diagnostic services and genomic testing. Triesta central reference laboratory is located in centre of excellence in Bengaluru.
Strengths of the Company:
1. Largest provider of cancer care in India with a proven track record
2. High quality cancer care provided at a competitive price
3. Entry into high potential fertility business
4. Strong management team with successful track record
5. Highly skilled specialist physicians
6. 'hub and spoke' business model and partnership arrangements
Dr. BS Ajai Kumar, Dr. KS Gopinath, Dr. Ganesh Nayak, Dr. M Gopichand and Dr. BS Ramesh are the Promoters of the Company.
|
Particulars |
For the year/period ended (in Rs. Million) | ||||
| 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | 31-Mar-12 | 31-Mar-11 | |
| Total Liabilities | 6,895.42 | 6,138.21 | 6,436.40 | 4,362.63 | 3,203.63 |
| Total Assets | 6,895.42 | 6,138.21 | 6,436.40 | 4,362.63 | 3,203.63 |
| Total Revenue | 4,244.41 | 3,525.94 | 2,939.52 | 2,051.67 | 1,601.43 |
| Profit After Tax (PAT) | (23.66) | (394.98) | (71.58) | (40.02) | 34.40 |
The Offer comprises of Fresh Issue and the Offer for Sale.
Offer for Sale
Company will not receive any proceeds from the Offer for Sale.
Fresh Issue
Company proposes to utilise the Net Proceeds towards funding the following objects:
1. Purchase of medical equipment;
2. Investment in IT software, services and hardware;
3. Pre-payment of debt; and
4. General corporate purposes.
| IPO Opening Date | Mar 16, 2016 |
| IPO Closing Date | Mar 18, 2016 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹205 to ₹218 per equity share |
| Market Lot | 65 Shares |
| Min Order Quantity | 65 Shares |
| Listing At | BSE, NSE |
| Issue Size | 29,800,000 Eq Shares of ₹10 (aggregating up to ₹649.64 Cr) |
The Healthcare Global IPO market lot size is 65 shares. A retail-individual investor can apply for up to 14 lots (910 shares or ₹198,380).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 65 | ₹14,170 |
| Maximum | 14 | 910 | ₹198,380 |
The Healthcare Global IPO is subscribed 1.56 times on 3/18/2016 1:00:00 PM. The public issue subscribed 0.83 in the retail category, 2.36 in the QIB category, and 0.43 in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 2.36 |
| NII | 0.43 |
| Retail | 0.83 |
| Total | 1.56 |
| Listing Date | Wednesday, March 30, 2016 |
| BSE Script Code | 539787 |
| NSE Symbol | HCG |
| Listing In | B Group of Securities |
| ISIN | INE075I01017 |
| IPO Price | ₹218 per equity share |
| Face Value | ₹10 per equity share |
|
|
|
Healthcare Global Enterprises Ltd
HCG Tower, No. 8, P Kalinga Rao Road,
Sampangi Rama Nagar,
Bengaluru 560 027
Phone: +91 80 4660 7700
Email: investors@hcgoncology.com
Website: http://www.hcgel.com
KFintech Private Limited
Phone: 04067162222, 04079611000
Email: einward.ris@karvy.com
Website: https://karisma.kfintech.com/
Healthcare Global IPO is a main-board IPO of 29,800,000 equity shares of the face value of ₹10 aggregating up to ₹649.64 Crores. The issue is priced at ₹205 to ₹218 per equity share. The minimum order quantity is 65 Shares.
The IPO opens on Mar 16, 2016, and closes on Mar 18, 2016.
KFintech Private Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Healthcare Global IPO opens on Mar 16, 2016 and closes on Mar 18, 2016.
Healthcare Global IPO lot size is 65 Shares and the minimum order quantity is 65 Shares.
You can apply in Healthcare Global IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Healthcare Global IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Healthcare Global IPO allotment status.
IPO Mentor (700+ Posts, 200+ Likes)
Useful Articles
IPO Guru (4000+ Posts, 4600+ Likes)
Top Contributor (200+ Posts)
